Symbiodx - a PAML and Cellnetix joint venture

Symbiodx is a national anatomic pathology and molecular oncology reference laboratory committed to helping pathologists and oncologists provide critical answers in treatment planning and improving patient outcomes. We take a consultative, service focused approach and believe that interactive diagnostic collaboration is at the heart of good healthcare. Symbiodx was founded in 2014 by PAML and CellNetix and is located in Seattle, Washington.